Pereiti į pagrindinį turinį
Home
language-selector-globe Lithuania | lt
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Lithuania
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Apie mus 
      • Novartis Lietuvoje 
      • Strategija 
      • Įvairovė ir įtrauktis 
      • Žmonės ir kultūra 
      • Produktai 
      • Susisiekite su mumis 
      Apie mus Apie mus
    • Pacientai ir slaugytojai 
      • Novartis įsipareigojimas pacientams ir slaugytojams 
      • Terapinės sritys 
      • Produktai 
      • Pranešti apie nepageidaujamą reiškinį 
        • Pranešti apie įtariamą nepageidaujamą reiškinį 
      • Parama pacientų organizacijoms 
      Gydytojas tikrina paciente su stratoskopu Pacientai ir slaugytojai
    • Sveikatos priežiūros specialistai 
      • Novartis interneto svetainė sveikatos priežiūros specialistams 
      • Produktai 
      • Novartis vystomų produktų asortimentas 
      • Pranešti apie nepageidaujamą reiškinį 
      • Bendradarbiavimas su sveikatos priežiūros specialistais 
      • Novartis klinikiniai tyrimai 
      Gydytojai kalbasi ligonineje Sveikatos priežiūros specialistai
    • Aplinkos apsauga, socialinė atsakomybė ir valdysena (ASV) 
      • Etika, rizikos valdymas ir atitiktis 
      • Prieinamumas 
      • Aplinkos tvarumas 
      • Pasaulinė sveikatos apsauga 
      • Etiškas elgesys 
        • Etikos kodeksas 
    • Naujienos 
      • Naujienų archyvas 
      • Susisiekite su mumis 
      A photo of people in a meeting hall Naujienos
    • Karjera 
      • Karjeros paieška 
      • Mūsų komandos 
      • Asmeninis augimas 
      • Jaunieji talentai 
      • Kaip mes dirbame 
      • Darbuotojų gerovė 
      • Įvairovė ir įtrauktis 
      • Apdovanojimai ir pripažinimas 
      Karjera Karjera
    • Koronavirusas 
      coronavirus-microscope-image Koronavirusas
    Vilniaus panorama Pagrindinis puslapis
  1. Pagrindinis puslapis
  2. Karjera
  3. Karjeros paieška
  • Sort by Sort ascending
  • Darbo pavadinimas
  • Svetainė
  • Vieta
  • Padalinys Sort descending
  • Veikla
  • Functional Area
  • Paskelbimo data
Darbo pavadinimas Svetainė Vieta Padalinys Sort descending Veikla Functional Area Paskelbimo data
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Rugp 12, 2024
Coordinator, Global Program Management and Portfolio Excellence INSURGENTES Mexico Biomedical Research CTS Research & Development Spa 15, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Rugp 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Rugp 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Rugp 12, 2024
TME Profiling Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Pharma Research Research & Development Lie 07, 2024
Clinical Sciences Trial Leader Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Pharma Research Research & Development Lie 10, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Rugp 12, 2024
Japan Program Clinical Head (IMM) Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Innovative Medicines Research & Development Rug 10, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Rugp 12, 2024
Director of Global & Swiss Media & Editorial Basel (City) Switzerland Corporate CTS Communications & Public Affairs Spa 18, 2024
EA & Program Coordinator Beijing (Beijing) China Corporate Affairs Innovative Medicines Communications & Public Affairs Rug 03, 2024
Vice President of European Public Affairs Vilvoorde Belgium Corporate Affairs Innovative Medicines Communications & Public Affairs Spa 10, 2024
Manager, Post Production & Video Services Hyderabad (Office) India Corporate Affairs CTS Communications & Public Affairs Spa 04, 2024
Office Manager – Public Affairs (f/m/d) Berlin West (Non-Sales Force) (Novartis Pharma GmbH) Germany Corporate Affairs Innovative Medicines Facilities & Administration Rug 02, 2024
Patient Engagement Lead İstanbul Kavacık Turkey Corporate Affairs CTS Communications & Public Affairs Rug 03, 2024
Executive Director, Public Affairs LaCan Region East Hanover USA Corporate Affairs Corporate Communications & Public Affairs Gegužė 09, 2024
Associate Director, Corporate Event Marketing Cambridge (USA) USA Corporate Affairs CTS Communications & Public Affairs Spa 16, 2024
Government Affairs Manager Moscow (City) Russian Fed. Corporate Affairs Innovative Medicines Communications & Public Affairs Lie 29, 2024
Manager, Corporate Marketing Creative & Design East Hanover USA Corporate Affairs CTS Communications & Public Affairs Spa 17, 2024
Director, Sustainability & ESG Strategy (Health Equity / Access focus) Basel (City) Switzerland Corporate Affairs Corporate BD&L & Strategic Planning Spa 15, 2024
Comms & Engagement Manager Amsterdam Netherlands Corporate Affairs CTS Communications & Public Affairs Spa 16, 2024
Executive Director, Therapy Area Communications and Patient Advocacy Basel (City) Switzerland Corporate Affairs CTS Communications & Public Affairs Spa 16, 2024
Manager, Digital Storytelling Remote Position (USA) USA Corporate Affairs CTS Communications & Public Affairs Spa 18, 2024
Associate Director, R&D Portfolio and Engagement - Communications Cambridge (Massachusetts) USA Corporate Affairs CTS Communications & Public Affairs Spa 08, 2024
Associate Director, Finance and Strategy & Growth Activation Communications East Hanover USA Corporate Affairs CTS Communications & Public Affairs Spa 08, 2024
Clinical Research Associate Beijing (Beijing) China Development Innovative Medicines Research & Development Spa 09, 2024
Research & Development Quality Specialist Barcelona Gran Vía Spain Development Innovative Medicines Quality Spa 15, 2024
Postgraduate Program in TRD-Biologics Basel (City) Switzerland Development Innovative Medicines Others Spa 15, 2024
Regulatory Affairs Manager Kyiv Ukraine Development Innovative Medicines Research & Development Gegužė 10, 2024
Global Program Clinical Head - Dermatology Basel (City) USA Development Innovative Medicines Research & Development Gegužė 15, 2024
Senior Vendor Program Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Gegužė 20, 2024
(Senior) Clinical Development Medical Director - Rheumatology East Hanover USA Development Innovative Medicines Research & Development Gegužė 20, 2024
Global Clinical Publishing Associate Hyderabad (Office) India Development Innovative Medicines Research & Development Rug 03, 2024
RA CMC Associate Manager-II Hyderabad (Office) India Development Innovative Medicines Research & Development Gegužė 30, 2024
Clinical Development Medical Manager Shanghai (Shanghai) China Development Innovative Medicines Research & Development Gegužė 30, 2024
Patient Safety Specialist İstanbul Kavacık Turkey Development Innovative Medicines Research & Development Bir 10, 2024
Head CD Pediatric CoE East Hanover USA Development Innovative Medicines Research & Development Bir 13, 2024
Global Program Head, Neuroscience East Hanover USA Development Innovative Medicines Research & Development Lie 16, 2024
RA CMC Associate Manager - II Hyderabad (Office) India Development Innovative Medicines Research & Development Bir 19, 2024
RA CMC Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Rug 03, 2024
Manager, Clinical Disclosure Office Barcelona Gran Vía Spain Development Innovative Medicines Research & Development Bir 20, 2024
Principal Biostatistician Shanghai (Shanghai) China Development Innovative Medicines Research & Development Bir 20, 2024
Senior Expert Science & Technology-Photochemistry Changshu (Jiangsu Province) China Development Innovative Medicines Research & Development Bir 28, 2024
Patient Safety Head US East Hanover USA Development Innovative Medicines Research & Development Bir 28, 2024
Group Head, Global Aggregate Reports & Risk Management Barcelona Gran Vía Spain Development Innovative Medicines Research & Development Rugp 29, 2024
Associate Director Data & Digitalization Project Management Schaftenau Austria Development Innovative Medicines Research & Development Rug 03, 2024
Associate Clinical Research Medical Director - Oncology RLT Remote Position (USA) USA Development Innovative Medicines Research & Development Rugp 29, 2024
Senior Clinical Development Medical Director - Renal East Hanover USA Development Innovative Medicines Research & Development Rugp 30, 2024
Global Regulatory Publishing Associate London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Rug 02, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 42
  • › Next page

Novartis Lietuvoje

Naršyti Novartis svetainėje
  • Pacientai ir slaugytojai
  • Sveikatos priežiūros specialistai
  • Kompanijos etika
  • Naujienos
  • Karjera
Naujienos
  • Naujienų archyvas
Musų portfelis
  • Novartis vystomų produktų asortimentas
  • Novartis produktai
Kitos Novartis svetainės
  • Pasaulinė svetainė
Footer Bottom
© 2024 Novartis AG
  • Privatumo politika
  • Naudojimo sąlygos
  • Slapukai
  • Slapukų nustatymai
  • Svetainės schema
  • Svetainės prieinamumas
Novartis svetainių katalogas
Ši svetainė skirta Lietuvos gyventojams